Articles

Novartis on Thursday said it will pay up to $1.75 billion for a U.S. biotech focused on cancer.

Tech giants’ recent earnings reveal a clear winner in market leadership and momentum.

Deliberately weakening social protections has created greater financial and economic insecurity.

Regeneron Pharmaceuticals’ stock fell 2.6% premarket Thursday, after the drug company’s first-quarter profit and revenue fell short of analyst estimates.

Moderna on Thursday reported a narrower-than-expected first-quarter loss as the COVID vaccine maker looks launch its second product in the U.S. later this year.

TikTok and Universal Music Group struck a new licensing deal that will return the record label’s artists and their songs to the popular video-sharing app, ending months of disagreements over pay.

“The biggest surprise when we got married was that my husband’s family saw me as a paycheck, even though they are all educated.”

“My business has been doing well lately, and I am able to take nice owner distributions of $10,000 to $30,000 per month,”

“Americans need to reprioritize their cash flow in difficult times,” according to one financial planner. “McDonald’s and Starbucks will survive.”

Dreaming of buying a house in today’s challenging real estate market? In this economy, you’ll need to make at least six figures — in most markets.

Shipping giant A.P. Moeller Maersk said it is planning to reroute cargo usually traveling through the Red Sea to the Cape of Good Hope for the remainder of the year, as it boosted financial guidance.

A team of UBS derivatives strategists led by Maxwell Grinacoff put together a playbook for a stagflation scenario